Cargando…

Anti-nucleocapsid IgG antibodies in SARS-CoV-2 recovered health care workers: One year follow-up study

Objective: The objective of this study was to evaluate the magnitude and durability of the anti-nucleocapsid-IgG antibody titer in healthcare workers previously infected with SARS-CoV-2 for a period of 12 months. Methods: This study examined blood samples for SARS-CoV-2-specific IgG collected period...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Ashfaq, Haq, Mohsina, Rehman, Asif, Haq, Najib Ul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328170/ https://www.ncbi.nlm.nih.gov/pubmed/37394899 http://dx.doi.org/10.1177/03946320231187744

Ejemplares similares

Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study
por: Mehboob, Saima, et al.
Publicado: (2022)

Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19
por: Haq, Mohsina, et al.
Publicado: (2022)

Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant
por: Chang, Chih-Chao, et al.
Publicado: (2021)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers
por: Cortés-Sarabia, Karen, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India
por: Lone, Kouser Sideeq, et al.
Publicado: (2022)

Role of specific IgE, IgG and IgG4 antibodies to corn dust in exposed workers
por: Park, Hae-Sim, et al.
Publicado: (1998)

Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
por: Van Elslande, Jan, et al.
Publicado: (2021)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
por: Tutukina, Maria, et al.
Publicado: (2021)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

COVID-19 vaccination and IgG and IgA antibody dynamics in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2021)

Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2
por: Liu, Pan-pan, et al.
Publicado: (2021)

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
por: Iles, Jason K., et al.
Publicado: (2022)

Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
por: Movsisyan, Mariam, et al.
Publicado: (2022)

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)

32 Decay of Anti-SARS-CoV-2 Nucleocapsid IgG in Seropositive Health Care Workers Over Time
por: Tiffany, B., et al.
Publicado: (2021)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Mouse IgG2a Antibodies Specific for the Commensal Streptococcus mitis Show Stronger Cross-Reactivity with Streptococcus pneumoniae than IgG1 Antibodies
por: Shekhar, Sudhanshu, et al.
Publicado: (2019)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity
por: Nückel, Julius, et al.
Publicado: (2022)

IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
por: Yang, Li, et al.
Publicado: (2021)

209 Seroprevalence of Anti-SARS CoV-2 Nucleocapsid IgG in a Cohort of Healthcare Workers Over Nine Months
por: The CONSERVE-HCW Research Group, et al.
Publicado: (2021)

Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
por: Noor, Mohammad, et al.
Publicado: (2020)

SARS-CoV-2: big seroprevalence data from Pakistan—is herd immunity at hand?
por: Haq, Mohsina, et al.
Publicado: (2021)

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease
por: Kiyama, Kazuhiro, et al.
Publicado: (2015)

Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study
por: Maina, Daniel, et al.
Publicado: (2022)

Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA
por: Yu, Fuxun, et al.
Publicado: (2015)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis
por: Li, Qiu, et al.
Publicado: (2023)

Incidence of Dengue fever, serotypes, clinical features, and laboratory markers: a case study of 2019 outbreak at district Shangla, KP, Pakistan
por: Rehman, Abid Ur, et al.
Publicado: (2022)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
por: Chu, Thach H., et al.
Publicado: (2020)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

SARS-CoV-2 specific IgG antibodies among participants presenting to a voluntary testing facility in Srinagar, Kashmir
por: Kousar, Rafiya, et al.
Publicado: (2022)

Detection of IgG antibody during the follow-up in patients with COVID-19 infection
por: Liu, Jiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jh0jvr6ut2kckvropd84b9pjko